Rekvina Laboratories Limited

₹64.04As of Sun 8 Nov 2026, 12:00 UTC
BSE:526075Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Pharmaceutical Preparations
Beta (5Y) 2.73
PE TTM —
TSR TTM —
Mkt cap ₹711.9M
ROIC (254.95%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹78
22.44%
(31.21%)
Sell 0|10|1|11|8
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
1.50
1.58
1.70
1.80
12.76%
20.97%
23.64%
24.26%
Revenue₹M
81.12
81.21
80.68
83.22
5.19%
0.81%
1.24%
4.18%
Peers (US$7.224M)
Cap (US$)
PE
8.426M
8.441x
Capital
TTM
5Y
10Y
Leveragex
3.142
(0.050)
(0.044)
EBIT/Intx
1.144
0.083
0.079
Own earn%
(10.52)
40.48
21.41
Sh yield%
58.14
27.29
25.07
Owners
Insiders/Inst%
4.97
44.74
Short interest%
3.48
SBC / revenue%
4.39
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
10–22
$1 testx
—
Incr. ROIC%
10